Abstract
The novel dopamine autoreceptor antagonists (−)-DS 121 and (+)-UH 232 were tested for their ability to alter cocaine self-administration behavior in rats reinforced on a progressive ratio (PR) schedule. (−)-DS 121 (15 mg/kg) and (+)-UH 232 (30 mg/kg) produced significant decreases in breaking point. (−)-DS 121 produced variable results on rate of cocaine intake on an FR1 schedule, indicating that rate may on occasion be insensitive to changes in cocaine reinforcement. In animals previously trained to self-administer cocaine, (−)-DS 121 failed to maintain responding when substituted for cocaine. This profile suggests that (−)-DS 121 is a promising new candidate for the treatment of cocaine abuse.
Similar content being viewed by others
References
Britton DR, Curzon P, Mackenzie RG, Kebabian JW, Williams JEG, Kerkman D (1991) Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol Biochem Behav 39:911–915
Corrigall WA, Coen KM (1991) Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39:799–802
Dalton JCH, Vickers GJ, Roberts DCS (1986) Increased self-administration of cocaine following haloperidol: sex-dependent effects of the antiestrogen tamoxifen. Pharmacol Biochem Behav 25:497–501
Dackis CA, Gold MS, Davies RK, Sweeney DR (1985) Bromocriptine treatment for cocaine abuse: The dopamine depletion hypothesis. Int J Psychiatry Med 15:125–135
Dackis CA, Gold MS, Sweeney DR, Byron JP Jr, Climko R (1987) Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 20:261–264
De Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with nonadrenergic blockers phentolamine and phenoxybenzamine. Can J Psychiatry 31:195–203
Depoortere RY, Li DH, Lane JD, Emmett-Oglesby MW (1993) Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 45:539–548
Drukarch B, Stoof JC (1990) D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 47:361–376
Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204–209
Gawin FH, Kleber HD (1984) Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 41:903–909
Gawin FH, Riordan C, Kleber HD (1985) Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 11:193–197
Gawin FH, Byck R, Kleber HD (1986) Desipramine augmentation of cocaine abstinence: initial results. Clin Neuropharmacol 9 [Suppl 4]:202–204
Gawin FH, Kleber HD, Byck R, Rounsaville BJ et al. (1989a) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117–121
Gawin FH, Morgan C, Kosten TR, Kleber HD (1989b) Doubleblind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology 97:402–403
Giannini AJ, Folts DJ, Feather JN, Sullivan BS (1989) Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res 29:11–16
Gifford AN, Johnson KM (1993) A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors. Eur J Pharmacol 237:169–175
Gui-Hua C, Woolverton WL (1991) Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors. Eur J Pharmacol 209:285–286
Hubner CB, Moreton JE (1991) Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105:151–156
Jaffe JH, Cascella NG, Kumor KM, Sherer MA (1989) Cocaine-induced cocaine craving. Psychopharmacology 97:59–64
Khalsa HK, Shaner A, Anglin MD, Wang J (1991) Prevalence of substance abuse in a psychiatric evaluation unit. Drug Alcohol Depend 28:215–223
Kling-Petersen T, Svensson K (1993) Effects of the preferential dopamine autoreceptor antagonist (+)-AJ 76 in the intracranial self-stimulation paradigm. Pharmacol Biochem Behav 43:495–501
Kling-Petersen T, Ljung E, Svensson K (1994) The preferential dopamine autoreceptor antagonist (+)-UH 232 antagonizes the positive reinforcing effects of cocaine andd-amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49:345–351
Koob GF, Le HT, Creese I (1987a) The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79:315–320
Koob GF, Vaccarino FJ, Amalric M, Bloom FE (1987b) Positive reinforcing properties of drugs: search for neural substrates In: Engel J, Oreland L (eds) Brain reward systems and abuse. Raven Press, New York, pp 35–50
Kosten TR, Schumann B, Wright D, Carney MK, Gawin FH (1987) A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients. J Clin Psychiatry 48:442–444
Loh EA, Roberts DCS (1990) Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology 101:262–266
McGregor A, Roberts DCS (1993) Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624:245–252
Meyer RE (1992) New pharmacotherapies for cocaine dependence...revisited. Arch Gen Psychiatry 49:900–904
Piercey MF, Lum JT (1990) Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232. Eur J Pharmacol 182:219–226
Richardson NR, Piercey MF, Svensson K, Collins RJ, Myers JE, Roberts DCS (1993) Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ 76. Brain Res 619:15–21
Richardson NR, Smith AM, Roberts DCS (1994) A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug Alcohol Depend 36:23–25
Roberts DCS (1989) Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 32:43–47
Roberts DCS (1992) Neural substrates mediating cocaine reinforcement: the role of monoamine systems Lakoski JM, Galloway MP, White FJ (eds) In: Cocaine: pharmacology, physiology and clinical strategies. CRC Press, Boca Raton, pp 73–90
Roberts DCS, Richardson NR (1992) Self-administration of psychomotor stimulants using progressive ratio schedules of reinforcement In: Wu P, Boulton A, Baker GB (eds) Neuromethods: animal models of drug addiction, vol. 24. Humana Press, Clifton, N.J., pp 263–269
Roberts DCS, Vickers GJ (1982) A typical neuroleptics increase self-administration of cocaine: a possible screening procedure for antipsychotic drugs. Soc. Neurosci Abstr 8:1
Roberts DCS, Vickers GJ (1984) A typical neuroleptics increase self-administration of cocaine: an evaluation of a behavioral screen for antipsychotic drug activity. Psychopharmacology 82:135–139
Roberts DCS, Bennett SAL, Vickers GJ (1989a) The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 98:408–411
Roberts DCS, Loh EA, Vickers GJ (1989b) Self-administration of cocaine on a progressive ratio schedule in rats: dose-response relationship and effect of haloperidol pretreatment. Psychopharmacology 97:535–538
Ruffolo RRJ (1982) Important concepts of receptor theory. J Auton Pharmacol 2:277–295
Salloum IM, Moss HB, Daley DC (1991) Substance abuse and schizophrenia: impediments to optimal care. Am J Drug Alcohol Abuse 17:321–336
Shaner A, Khalsa ME, Roberts L, Wilkins J, Anglin D, Hsieh S-C (1993) Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 150:758–762
Svensson KA, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson L-E, Hacksell U, Nilsson JLG (1986a) (+)-UH 232 and (+)-AJ 76: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. J Neural Transm 65:1–27
Svensson KA, Johansson AM, Magnusson T, Carlsson A (1986b) (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedebergs Arch Pharmacol 334:234–245
Svensson KA, Waters N, Carlsson A (1993) (-)-DS 121, a novel dopamine D3- and autoreceptor preferring antagonist: effects on locomotor activity in the rat. Soc Neurosci Abstr 19:80
Tennant FS, Sagherian AA (1987) Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Int Med 147:109–112
Waters N, Lagerkvist S, Löfberg L, Piercey M, Carlsson A (1993a) The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ 76 and (+)-UH 232; a microdialysis study. Eur J Pharmacol 242:151–163
Waters N, Sonesson C, Svensson KA (1993b) (−)-DS 121, a novel dopamine D3- and autoreceptor preferring antagonist: biochemical and electrophysiological effects. Soc Neurosci Abstr 19:80
Wilson MC, Schuster CR (1972) The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacology 26:115–126
Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193–200
Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide: implications for a dopamine theory of reward. Science 187:547–549
Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311–318
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, A., Roberts, D.C.S. & Piercey, M. Effect of (−)-DS 121 and (+)-UH 232 on cocaine self-administration in rats. Psychopharmacology 120, 93–98 (1995). https://doi.org/10.1007/BF02246149
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246149